Form 4/A for NGVT Ingevity Corp

Accepted 2021-12-17 00:00:00 ET · period of report 2021-02-26 · accession 0001493152-21-031949 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DA	2021-12-17	2021-02-26	NGVT	WOODCOCK STUART EDWARD JR.	EVP, Pres Perf Materials	A - Grant	$0.00	+7,197	26.0K	+38%	$0
DA	2021-12-17	2021-02-26	NGVT	WOODCOCK STUART EDWARD JR.	EVP, Pres Perf Materials	A - Grant	$0.00	+4,144	4,144	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Employee Stock Option (right-to-buy)	2021-02-26	A	A	7,197	$0.00	26,034	D	—	—	(F1) The reporting person's Form 4 filed with the SEC on March 2, 2021 inadvertently reported an incorrect vesting schedule for restricted stock units granted on February 26, 2021 pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. The restricted stock units will vest on February 26, 2024. This amendment is being filed to correct: (a) the vesting schedule for this grant; (b) the exercise price for an Employee Stock Option (right-to-buy) addressed in Footnote 2, below; and (c) to correct the signature line of the prior report.
2	Derivative	Employee Stock Option (right-to-buy)	2021-02-26	A	A	4,144	$0.00	4,144	D	$69.48 · 2022-02-26 to 2031-02-26	4,144 Common Stock	(F2) The reporting person's Form 4 filed with the SEC on March 2, 2021 inadvertently reported an incorrect exercise price with respect to the Employee Stock Option (right-to-buy). (F3) These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 26, 2022, 2023 and 2024.